Comparison of the Internal Fatigue Crack Initiation and Propagation Behavior of a Quenched and Tempered Steel with and without a Thermomechanical Treatment

Previous studies have shown that a thermomechanical treatment (TMT) consisting of cyclic plastic deformation in the temperature range of dynamic strain aging can increase the fatigue limit of quenched and tempered steels by strengthening the microstructure around non-metallic inclusions. This study considers the influence of a TMT on the shape, size and position of crack-initiating inclusions as well as on the internal crack propagation behavior. For this, high cycle fatigue tests on specimens with and without TMT were performed at room temperature at a constant stress amplitude. The TMT increased the average lifetime by about 40%, while there was no effect of the TMT on the form or size of critical inclusions. Surprisingly, no correlation between inclusion size and lifetime could be found for both specimen types. There is also no correlation between inclusion depth and lifetime, which means that the crack propagation stage covers only a small portion of the overall lifetime. The average depth of critical inclusions is considerably higher for TMT specimens indicating that the strengthening effect of the TMT is more pronounced for near-surface inclusions. Fisheye fracture surfaces around the critical inclusions could be found on all tested specimens. With increasing fisheye size, a transition from a smooth to a rather rough and wavy fracture surface could be observed for both specimen types

Influence of a Thermo-Mechanical Treatment on the Fatigue Lifetime and Crack Initiation Behavior of a Quenched and Tempered Steel

A thermo-mechanical treatment (TMT) at the temperature of maximum dynamic strain aging has been optimized and performed on quenched and tempered steel SAE4140H (German designation: 42CrMo4) in order to improve the fatigue limit in the high cycle fatigue (HCF) and and very high cycle fatigue (VHCF) regimes. Fatigue tests, with ultimate cycle numbers of 107 and 109, have shown that the TMT can increase both the fatigue lifetime and the fatigue limit in the HCF and VHCF regimes. The increased stress intensity factors of the critical inclusions after the TMT indicate that the effect can be attributed to a stabilized microstructure around critical crack-initiating inclusions through the locking of edge dislocations by carbon atoms during the TM

Consensus Middle East and North Africa Registry on Inborn Errors of Immunity

Background: Inborn errors of immunity (IEIs) are a heterogeneous group of genetic defects of immunity, which cause high rates of morbidity and mortality mainly among children due to infectious and non-infectious complications. The IEI burden has been critically underestimated in countries from middle- and low-income regions and the majority of patients with IEI in these regions lack a molecular diagnosis. Methods: We analyzed the clinical, immunologic, and genetic data of IEI patients from 22 countries in the Middle East and North Africa (MENA) region. The data was collected from national registries and diverse databases such as the Asian Pacific Society for Immunodeficiencies (APSID) registry, African Society for Immunodeficiencies (ASID) registry, Jeffrey Modell Foundation (JMF) registry, J Project centers, and International Consortium on Immune Deficiency (ICID) centers. Results: We identified 17,120 patients with IEI, among which females represented 39.4%. Parental consanguinity was present in 60.5% of cases and 27.3% of the patients were from families with a confirmed previous family history of IEI. The median age of patients at the onset of disease was 36 months and the median delay in diagnosis was 41 months. The rate of registered IEI patients ranges between 0.02 and 7.58 per 100,000 population, and the lowest rates were in countries with the highest rates of disability-adjusted life years (DALY) and death rates for children. Predominantly antibody deficiencies were the most frequent IEI entities diagnosed in 41.2% of the cohort. Among 5871 patients genetically evaluated, the diagnostic yield was 83% with the majority (65.2%) having autosomal recessive defects. The mortality rate was the highest in patients with non-syndromic combined immunodeficiency (51.7%, median age: 3.5 years) and particularly in patients with mutations in specific genes associated with this phenotype (RFXANK, RAG1, and IL2RG). Conclusions: This comprehensive registry highlights the importance of a detailed investigation of IEI patients in the MENA region. The high yield of genetic diagnosis of IEI in this region has important implications for prevention, prognosis, treatment, and resource allocation

Influence of a Thermo-Mechanical Treatment on the Fatigue Lifetime and Crack Initiation Behavior of a Quenched and Tempered Steel

A thermo-mechanical treatment (TMT) at the temperature of maximum dynamic strain aging has been optimized and performed on quenched and tempered steel SAE4140H (German designation: 42CrMo4) in order to improve the fatigue limit in the high cycle fatigue (HCF) and and very high cycle fatigue (VHCF) regimes. Fatigue tests, with ultimate cycle numbers of 107 and 109, have shown that the TMT can increase both the fatigue lifetime and the fatigue limit in the HCF and VHCF regimes. The increased stress intensity factors of the critical inclusions after the TMT indicate that the effect can be attributed to a stabilized microstructure around critical crack-initiating inclusions through the locking of edge dislocations by carbon atoms during the TMT

Influence of a Thermo-Mechanical Treatment on the Fatigue Lifetime and Crack Initiation Behavior of a Quenched and Tempered Steel

A thermo-mechanical treatment (TMT) at the temperature of maximum dynamic strain aging has been optimized and performed on quenched and tempered steel SAE4140H (German designation: 42CrMo4) in order to improve the fatigue limit in the high cycle fatigue (HCF) and and very high cycle fatigue (VHCF) regimes. Fatigue tests, with ultimate cycle numbers of 107 and 109, have shown that the TMT can increase both the fatigue lifetime and the fatigue limit in the HCF and VHCF regimes. The increased stress intensity factors of the critical inclusions after the TMT indicate that the effect can be attributed to a stabilized microstructure around critical crack-initiating inclusions through the locking of edge dislocations by carbon atoms during the TM

Long-term evaluation of a historical cohort of Iranian common variable immunodeficiency patients

Objectives: Common variable immune deficiency (CVID) is the most frequent form of symptomatic primary immunodeficiency disease, characterized by hypogammaglobulinemia, recurrent infections and increased predisposition to autoimmunity and malignancies. The aim of this study was to reconsider important points of previously performed studies on Iranian CVID patients diagnosed and followed from 1984 to 2013. Methods: Diagnosis was made using approved criteria including reductions of serum levels of immunoglobulins and exclusion of well-known single gene defects in individuals with an age >4 years and evidence of specific antibody deficiency. Results: Detailed information on demographic data, survival rates, clinical phenotypes, immunologic and genetic data and treatment of 173 patients are provided. The early onset presentation (74.5) and rate of consanguineous marriage (61.2) were considerably higher in our cohort. Our study revealed clinically related correlations regarding consanguinity, the population of naïve CD4+T cells and switched-memory B cells, cytokine levels and special genetic factors (including HLA and AID genes). Conclusion: Despite current efforts, more comprehensive studies are needed, especially for classification and investigation of the genetic background and prognostic factors for patients with CVID in order to better managment and followup of patinets. © 2014 Informa UK, Ltd

Fourth Update on the Iranian National Registry of Primary Immunodeficiencies: Integration of Molecular Diagnosis

Abstract Background The number of inherited diseases and the spectrum of clinical manifestations of primary immunodeficiency disorders (PIDs) are ever-expanding. Molecular diagnosis using genomic approaches should be performed for all PID patients since it provides a resource to improve the management and to estimate the prognosis of patients with these rare immune disorders. Method The current update of Iranian PID registry (IPIDR) contains the clinical phenotype of newly registered patients during last 5 years (2013–2018) and the result of molecular diagnosis in patients enrolled for targeted and next-generation sequencing. Results Considering the newly diagnosed patients (n = 1395), the total number of registered PID patients reached 3056 (1852 male and 1204 female) from 31 medical centers. The predominantly antibody deficiency was the most common subcategory of PID (29.5%). The putative causative genetic defect was identified in 1014 patients (33.1%) and an autosomal recessive pattern was found in 79.3% of these patients. Among the genetically different categories of PID patients, the diagnostic rate was highest in defects in immune dysregulation and lowest in predominantly antibody deficiencies and mutations in the MEFV gene were the most frequent genetic disorder in our cohort. Conclusions During a 20-year registration of Iranian PID patients, significant changes have been observed by increasing the awareness of the medical community, national PID network establishment, improving therapeutic facilities, and recently by inclusion of the molecular diagnosis. The current collective study of PID phenotypes and genotypes provides a major source for ethnic surveillance, newborn screening, and genetic consultation for prenatal and preimplantation genetic diagnosis. Keywords Epidemiology Iran primary immunodeficiency molecular diagnosi

Comparison of Common Monogenic Defects in a Large Predominantly Antibody Deficiency Cohort

Background: Predominantly antibody deficiencies (PADs) are the most common primary immunodeficiencies, characterized by hypogammaglobulinemia and inability to generate effective antibody responses. Objective: We intended to report most common monogenic PADs and to investigate how patients with PAD who were primarily diagnosed as suffering from agammaglobulinemia, hyper-IgM (HIgM) syndrome, and common variable immunodeficiency (CVID) have different clinical and immunological findings. Methods: Stepwise next-generation sequencing and Sanger sequencing were performed for confirmation of the mutations in the patients clinically diagnosed as suffering from agammaglobulinemia, HIgM syndrome, and CVID. Results: Among 550 registered patients, the predominant genetic defects associated with agammaglobulinemia (48 Bruton's tyrosine kinase BTK and 6 μ heavy chain deficiencies), HIgM syndrome (21 CD40 ligand and 7 activation-induced cytidine deaminase deficiencies), and CVID (17 lipopolysaccharides-responsive beige-like anchor deficiency and 12 atypical Immunodeficiency, Centromeric instability, and Facial dysmorphism syndromes) were identified. Clinical disease severity was significantly higher in patients with μ heavy chain and CD40 ligand mutations compared with patients with BTK (P = .003) and activation-induced cytidine deaminase (P = .009) mutations. Paralysis following live polio vaccination was considerably higher in patients with μ heavy chain deficiency compared with BTK deficiency (P < .001). We found a genotype-phenotype correlation among patients with BTK mutations regarding clinical manifestation of meningitis and chronic diarrhea. Surprisingly, we noticed that first presentations in most patients with Immunodeficiency, Centromeric instability, and Facial dysmorphism were respiratory complications (P = .008), whereas first presentations in patients with lipopolysaccharides-responsive beige-like anchor deficiency were nonrespiratory complications (P = .008). Conclusions: This study highlights similarities and differences in the clinical and genetic spectrum of the most common PAD-associated gene defects. This comprehensive comparison will facilitate clinical decision making, and improve prognosis and targeted treatment. © 2018 American Academy of Allergy, Asthma & Immunolog

Comparison of Common Monogenic Defects in a Large Predominantly Antibody Deficiency Cohort

BACKGROUND: Predominantly antibody deficiencies (PADs) are the most common primary immunodeficiencies, characterized by hypogammaglobulinemia and inability to generate effective antibody responses. OBJECTIVE: We intended to report most common monogenic PADs and to investigate how patients with PAD who were primarily diagnosed as suffering from agammaglobulinemia, hyper-IgM (HIgM) syndrome, and common variable immunodeficiency (CVID) have different clinical and immunological findings. METHODS: Stepwise next-generation sequencing and Sanger sequencing were performed for confirmation of the mutations in the patients clinically diagnosed as suffering from agammaglobulinemia, HIgM syndrome, and CVID. RESULTS: Among 550 registered patients, the predominant genetic defects associated with agammaglobulinemia (48 Bruton's tyrosine kinase BTK and 6 mu heavy chain deficiencies), HIgM syndrome (21 CD40 ligand and 7 activation-induced cytidine deaminase deficiencies), and CVID (17 lipopolysaccharides-responsive beige-like anchor deficiency and 12 atypical Immunodeficiency, Centromeric instability, and Facial dysmorphism syndromes) were identified. Clinical disease severity was significantly higher in patients with mu heavy chain and CD40 ligand mutations compared with patients with BTK (P = .003) and activation-induced cytidine deaminase (P = .009) mutations. Paralysis following live polio vaccination was considerably higher in patients with mu heavy chain deficiency compared with BTK deficiency (P < .001). We found a genotype-phenotype correlation among patients with BTK mutations regarding clinical manifestation of meningitis and chronic diarrhea. Surprisingly, we noticed that first presentations in most patients with Immunodeficiency, Centromeric instability, and Facial dysmorphism were respiratory complications (P = .008), whereas first presentations in patients with lipopolysaccharides-responsive beige-like anchor deficiency were nonrespiratory complications (P = .008). CONCLUSIONS: This study highlights similarities and differences in the clinical and genetic spectrum of the most common PAD-associated gene defects. This comprehensive comparison will facilitate clinical decision making, and improve prognosis and targeted treatment